Evidence map›Paper›PMID 27516811›Full record

ArticleJournal of cheminformatics2016

Large-scale ligand-based predictive modelling using support vector machines.

Jonathan Alvarsson, Samuel Lampa, Wesley Schaal, Claes Andersson, Jarl E S Wikberg, Ola Spjuth

Abstract read
In one paragraph

Article in Journal of cheminformatics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Machine Learning Strategies When Transitioning between Biological Assays.Journal of chemical information and modeling · 2021
    Article
  10. Article
  11. Towards reproducible computational drug discovery.Journal of cheminformatics · 2020
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jonathan AlvarssonDepartment of Pharmaceutical Biosciences, Uppsala University, 751 24 Uppsala, Sweden.
Samuel LampaDepartment of Pharmaceutical Biosciences, Uppsala University, 751 24 Uppsala, Sweden.
Wesley SchaalDepartment of Pharmaceutical Biosciences, Uppsala University, 751 24 Uppsala, Sweden ; Science for Life Laboratory, Uppsala University, 751 24 Uppsala, Sweden.
Claes AnderssonDepartment of Medical Sciences, Uppsala University, 751 85 Uppsala, Sweden.
Jarl E S WikbergDepartment of Pharmaceutical Biosciences, Uppsala University, 751 24 Uppsala, Sweden.
Ola SpjuthDepartment of Pharmaceutical Biosciences, Uppsala University, 751 24 Uppsala, Sweden ; Science for Life Laboratory, Uppsala University, 751 24 Uppsala, Sweden.ORCID 0000-0002-8083-2864

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The increasing size of datasets in drug discovery makes it challenging to build robust and accurate predictive models within a reasonable amount of time. In order to investigate the effect of dataset sizes on predictive performance and modelling time, ligand-based regression models were trained on open datasets of varying sizes of up to 1.2 million chemical structures. For modelling, two implementations of support vector machines (SVM) were used. Chemical structures were described by the signatures molecular descriptor. Results showed that for the larger datasets, the LIBLINEAR SVM implementation performed on par with the well-established libsvm with a radial basis function kernel, but with dramatically less time for model building even on modest computer resources. Using a non-linear kernel proved to be infeasible for large data sizes, even with substantial computational resources on a computer cluster. To deploy the resulting models, we extended the Bioclipse decision support framework to support models from LIBLINEAR and made our models of logD and solubility available from within Bioclipse.

Indexed as

BioclipseMolecular signaturesPredictive modellingQSARSupport vector machine

Identifiers

PMID27516811
PMCPMC4980776

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.